Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00063401
Status:
COMPLETED
Last Update Posted:
2010-04-08
First Post:
2003-06-25
Brief Title:
Phase II Study in Patients With Epidermal Growth Factor Receptor EGFR Advanced Stage Ovarian Primary Peritoneal and Fallopian Tube Cancer
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company